Answers are grounded in this paper and cite their sources.
Thymidine, in the absence of hypoxanthine, failed to protect normal mice from the acute toxicity of methotrexate, though tumor-bearing animals could be protected with thymidine alone, probably as a result of the availability of DNA degradation products released from drug-sensitive tumor cells. Although metrotrexate induced an early purine deficiency in gut cells, this effect was not detected in bone marrow. Later, purine deficiency became apparent in the gut and bone marrow of methotrexate-treated animals.
No takes yet. Share an insight, caveat, or question.
Straw et al. (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: